Novo Nordisk eyes to bring blockbuster weight-loss drug Wegovy to India in 2026 Ruchika Sharma1 Oct 2023 1:00 PM ISTNovo charges more than $1300 in the U.S. for a monthly supply and about 300 euros ($317) a month in Germany.
Can semaglutide and empagliflozin combo lower albuminuria in patients with type 2 diabetes? Medha Baranwal30 Sept 2023 11:45 AM ISTDenmark: A randomized and placebo-controlled study investigated the albuminuria-lowering effect of semaglutide addition on top of empagliflozin in...
Medical Bulletin 27/September/2023 Isra Zaman27 Sept 2023 3:15 PM ISTHere are the top medical news of the day:Tirzepatide outperforms Semaglutide in controlling Blood Sugar and Weight Loss in Type 2 Diabetes A new...
Tirzepatide outperforms Semaglutide in controlling Blood Sugar and Weight Loss in Type 2 Diabetes Isra Zaman27 Sept 2023 9:00 AM ISTA new meta-analysis of 22 studies, presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany,...
Tirzepatide found more effective for control of blood sugar and body weight than semaglutide Dr. Kamal Kant Kohli25 Sept 2023 11:45 AM ISTResearchers at Aristotle University of Thessaloniki, Thessaloniki, Greece have found in a new meta-analysis that tirzepatide is superior to...
Semaglutide in newly diagnosed type 1 diabetes patients eliminates need for insulin injections Dr. Kamal Kant Kohli8 Sept 2023 11:00 AM ISTUSA: Treatment with semaglutide among newly diagnosed Type 1 diabetes patients may drastically lower or even eliminate the need for insulin...
Semaglutide treatment may substantially reduce obesity prevalence and CVD events Niveditha Subramani23 Aug 2023 10:00 AM ISTCardiovascular diseases (CVD) and obesity are linked over a long period of time, with growing medical sciences newer management methods are brought to...
Eli Lilly concludes acquisition of Versanis Bio Ruchika Sharma18 Aug 2023 5:14 PM ISTIndianapolis: Eli Lilly and Company has announced the successful completion of its acquisition of Versanis Bio. The acquisition expands...
Semaglutide may reduce MACE among overweight patients with CVD Dr. Kamal Kant Kohli10 Aug 2023 10:30 AM ISTBagsværd: According to topline data from the SELECT study, Compared with placebo injectable semaglutide 2.4 mg reduced risk for major adverse CV...
GLP-1 agonists may hasten progression of diabetic retinopathy Dr. Kamal Kant Kohli7 Aug 2023 11:30 AM ISTUSA: Studies have linked the use of GLP-1 receptor agonists with exacerbation of macular disease that frequently occurs in diabetes...
UK probes Novo Nordisk Ozempic, Saxenda over suicidal, self-harming thoughts Ruchika Sharma27 July 2023 2:30 PM ISTLondon: Britain is reviewing a class of drugs used in a diabetes medicine and a weight-loss treatment sold by Novo Nordisk after some patients...
Eli Lilly to acquire Versanis for USD 1.925 billion Ruchika Sharma15 July 2023 1:00 PM ISTIndianapolis: Eli Lilly and Company and Versanis Bio have announced a definitive agreement for Lilly to acquire Versanis, a private...
